These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7672153)

  • 21. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous gonadotropin stimulation is associated with increases in serum androgen levels in in-vitro fertilization-embryo transfer cycles.
    Martin KA; Hornstein MD; Taylor AE; Hall JE; Barbieri RL
    Fertil Steril; 1997 Dec; 68(6):1011-6. PubMed ID: 9418689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer.
    Abuzeid MI; Sasy MA
    Fertil Steril; 1996 May; 65(5):981-5. PubMed ID: 8612861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone.
    Ron-El R; Herman A; Golan A; Soffer Y; Nachum H; Caspi E
    Fertil Steril; 1992 Dec; 58(6):1164-8. PubMed ID: 1459267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of bushen tiaojing recipe on the quality of the oocytes and reproductive hormones in the follicular fluid in IVF-ET patients].
    Liang Y; Du HL; Chang XF; Zhao SN; Lei LM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):911-6. PubMed ID: 25223171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation.
    Copperman AB; Horowitz GM; Kaplan P; Scott RT; Navot D; Hofmann GE
    Fertil Steril; 1995 Jun; 63(6):1267-71. PubMed ID: 7750599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
    Yang TS; Wang BC; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of hormonal changes during combined buserelin/HMG treatment.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Runnebaum B
    Hum Reprod; 1990 Aug; 5(6):675-81. PubMed ID: 2123882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
    Younis JS; Matilsky M; Radin O; Ben-Ami M
    Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relation between the outcome of IVF-ET and subtle rise in serum progesterone during the follicular phase stimulated with a combination of gonadotropin-releasing hormone analog and gonadotropin].
    Sekijima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):249-55. PubMed ID: 8492012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Sep; 108(3):505-512.e2. PubMed ID: 28697910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome.
    Khalaf Y; Taylor A; Braude P
    Fertil Steril; 2000 Jul; 74(1):63-6. PubMed ID: 10899498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian 11 beta-hydroxysteroid dehydrogenase activity is inversely related to the outcome of in vitro fertilization-embryo transfer treatment cycles.
    Michael AE; Gregory L; Piercy EC; Walker SM; Shaw RW; Cooke BA
    Fertil Steril; 1995 Sep; 64(3):590-8. PubMed ID: 7641915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
    Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
    Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of day 3 estradiol on in vitro fertilization outcome.
    Smotrich DB; Widra EA; Gindoff PR; Levy MJ; Hall JL; Stillman RJ
    Fertil Steril; 1995 Dec; 64(6):1136-40. PubMed ID: 7589666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.